Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05524857
Title Combination of Fedratinib and Decitabine for Myeloproliferative Neoplasms (MPN)- Accelerated Phase (AP)/Blast Phase (BP)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Joseph Jurcic
Indications

myeloproliferative neoplasm

Therapies

Decitabine + Fedratinib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.